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Background: The anterolateral approach is a commonly used technique for total hip replacement. It requires the
detachment of a large part of the gluteus medius muscle. However, it is known that this muscle has a great impact
on hip stability. Using the percutaneous assisted approach the damage to the gluteus medius can be limited. The
purpose of this study is to compare the effect of the percutaneous assisted approach with the anterolateral
approach on postoperative functional outcome.
Methods/Design: This study uses a prospective, randomized, parallel-group design with blinded assessment and
unblinded treatment to compare the percutaneous assisted approach with the anterolateral approach in total hip
replacement surgery. The postoperative results of patients operated on using the percutaneous assisted approach
will be compared with those of patients operated on using the anterolateral approach. Prior to surgery patients will
undergo baseline measurements. These will consist of gluteus medius measurements (surface-electromyography,
strength measurements of abductors and quadriceps and the Trendelenburg test), questionnaires (Oxford Hip
Score and 36-item Short Form Health Survey) and functional measures (the Timed Get-Up-and-Go test, Five times
Sit-to-Stand test and Six-Minute Walk test). These measurements will be repeated four and 12 weeks after surgery.
After surgery both groups will receive usual care.
Discussion: The gluteus medius is the main stabilizer of the hip joint. Therefore, we assume that functional
outcome and gluteus medius function of patients after the percutaneous assisted approach will be better than after
the anterolateral approach.
Trial registration: This trial was registered with ClinicalTrials.gov on 8 January 2014, registration number: NCT02032017.
Keywords: Total hip replacement, Approach, Gluteus medius, Rehabilitation, Functional outcomeBackground
Total hip replacement (THR) is one of the most com-
mon orthopedic operations. Based on implant sales
figures in the Benelux region of Europe (Belgium, The
Netherlands and Luxembourg), the number of THR sur-
geries performed in 2001 has been estimated at 40,000
(1.52 THR per 1,000 inhabitants per year) [1]. Every
THR has an estimated cost of €9000 on average [2] and* Correspondence: willem.dehertogh@uantwerpen.be
1Faculty of Medicine and Health Sciences, University of Antwerp,
Universiteitsplein 1, 2610 Antwerp, Belgium
Full list of author information is available at the end of the article
© 2014 Hendrickx et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.the length of hospital stay and postoperative care are
contributing factors to these costs [2].
Improvements in health-related quality of life (HRQoL)
after surgery are reported. However, significant differences
between patients and age- and sex-matched controls are
noted. An example of this is the scores of the 36-item
Short Form Health Survey (SF-36) subscales physical func-
tioning (PF) (P = 0.01), role physical (RP) (P = 0.05) and
vitality (P = 0.05) [3]. These lower scores suggest that al-
though patients demonstrate full recovery on psychosocial
and pain scales, a deficit in physical functioning remains.
This lack of functional recovery has also been found in aral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 Percutaneous assisted approach, side view.
Figure 2 Percutaneous assisted approach, top view.
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patients (measured by self-perceived function, clinical
measures and actual daily activity) had only recovered to
about 80% of that of controls [4]. Furthermore, Rasch
et al. found persisting muscle atrophy two years after sur-
gery in the acting muscles around the hip [5]. This was
caused by loss of muscle volume as well as infiltration of
fat tissue.
Postoperative outcome can be influenced by the ap-
plied surgical procedure. Two approaches are used to
perform THR, with the posterior approach being most
commonly used in the USA. Leg lengthening and an in-
creased dislocation rate are the downsides [6-8]. A
popular technique in Europe is the anterolateral ap-
proach (AA). By using this, a large part of the gluteus
medius muscle is released to obtain good access to the
acetabulum. There are little or no dislocations reported
[9], but limping during the first three months is a well-
known problem [6,7].
Muscles are major contributors to hip contact force,
with gravitational and centrifugal forces combined con-
tributing less than 5%. One of the most important mus-
cles for this is the gluteus medius [10]. It is responsible
for stabilizing the femoral neck in the acetabulum during
the different stages of gait [11,12]. This makes it a very
important muscle for normal functioning and gait. The
gluteus medius is often already weakened before surgery
in patients with osteoarthritis of the hip [13]. Since the
AA detaches approximately two thirds of the gluteus
medius, it affects normal function. Consequently, it can
be assumed that interventions sparing the gluteus med-
ius are probably beneficial for patients’ postoperative
functional outcome.
Damage to the gluteus muscle can be limited using the
percutaneous assisted approach (PAA). In this technique,
a second small incision (1 cm) at the anterior border of
the femur is made. A canula is placed underneath the
muscle and used to pass the reamers in the direction of
the acetabulum (Figures 1 and 2). There is no need to en-
large the skin incision or to release more muscle insertion
to achieve good working access to the acetabulum. There
are two advantages of this procedure: sparing of the glu-
teus medius muscle and safe access to the acetabulum to
obtain perfect positioning of the implants.
Interventions sparing the gluteus medius are probably
beneficial for patients’ postoperative functional outcome.
The purpose of this study is to evaluate the effect of the PAA
on postoperative functional outcome compared to the AA.
Methods/Design
Study design
This study uses a prospective, randomized, parallel-group
design with blinded assessment and unblinded treatment
to compare the PAA with the AA in THR surgery.Ethical approval
Full ethical approval has been given by the ethics com-
mittee of the Antwerp University Hospital (UZA) and
Hospital Network Antwerp (ZNA) (approval number:
B300201318915).
Patient selection
Patients will be recruited at the orthopedics department of
the ZNA Middelheim hospital in Antwerp, Belgium. Pa-
tients with a hip complaint for which THR is indicated are
screened for eligibility by a specialized surgeon (PM). Eli-
gible patients will be between 50 and 80-years-old and suf-
fer from unilateral hip arthritis or avascular necrosis in
need of THR. Comorbidities affecting functional outcome
will be used as exclusion criteria. These consist of symp-
tomatic lumbar pathology or those in need of surgery or
intervention on the ipsilateral knee and/or ankle or foot.
Additionally, neurological disorders, according to the
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disease and previous cardiovascular accidents (CVA) are
excluded from this study.
Eligible patients who provide informed consent will be
sent to the Antwerp University Hospital (UZA) where
an appointment for preoperative (baseline) measure-
ments will be made. These consist of gluteus medius
measures, HRQoL-questionnaires and functional mea-
sures. Patients will be given an information sheet and a
written informed consent will be obtained prior to base-
line measurements.
Gluteus medius measures
Surface-electromyography of gluteus medius muscle
Patients will perform a single leg stance (SLS) and a max-
imal voluntary isometric contraction (MVIC) of the glu-
teus medius during surface-electromyography (SEMG)
measurement. Both have shown excellent reliability (SLS
intraclass correlation coefficient (ICC) = 0.93; MVIC ICC =
0.98) [14]. Electrodes will be positioned 2.5 cm posterior
of the middle of the line between the top of the iliac crest
and the greater trochanter. This is more posterior than
the method of Hermens et al. [15]. This decision is based
on a cadaver-study by Van Leemput et al. (Van Leemput
W, Collier E, Saeys N, Stassijns G: Measuring tensor
fasciae latae and gluteus medius with surface EMG: a
cadaver-based study. Unpublished). They demonstrated
that the distance from the needle tract to the central point
of the muscle was significantly less when the electrodes
were placed more posterior (P <0.0001). Therefore we pre-
fer this method.
Quadriceps and abductor muscle strength
Quadriceps and abductor strength will be measured with
the microFET 2 hand-held dynamometer (Biometrics
Motion nv, Almere, The Netherlands). Measurements
with this device are highly reliable, with excellent intrara-
ter reliability (ICC 0.921 to 0.929) and valid, with high cor-
relations with the Timed Get-Up-and-Go test (TGUG)
(r =−0.710 to −0.862) and gait speed (r = 0.728 to 0.825) [16].
For quadriceps force the patient is seated with the
knees bent 90°. Resistance will be administered on the
ventral side of the lower leg, just proximal of the ankle
joint. Abductor force will be measured in a supine pos-
ition. Resistance will be administered on the lateral side
of the upper leg, just proximal of the knee joint. Patients
will be asked for a MVIC. The tests will be repeated
three times. The mean value of the three measurements
will be recorded.
Trendelenburg test
This test measures abductor force in a functional way.
The patient is asked to raise one leg (sound side) and
raise the non-stance side of the pelvis as high aspossible for 30 seconds. The response is classified as
followed [17]:
1. Normal: The pelvis on the non-stance side can be
lifted maximally for 30 seconds.
2. The pelvis on the non-stance side can be lifted but
not maximally
3. The pelvis is elevated but not maintained for 30
seconds
4. No elevating of the pelvis on the non-stance side
5. Drooping of the pelvis
6. Non-valid response: due to hip pain or
uncooperative patient
Test-retest reliability coefficients (κ) are found to be
greater than 0.75 [18].
HRQoL-questionnaires
All patients will be required to complete the Oxford Hip
Score (OHS) and the 36-item Short Form Health Survey
(SF-36) questionnaires. The OHS is a disease-specific
questionnaire that consists of 12 questions for the evalu-
ation of pain and hip function in relation to various ac-
tivities. Each question contains five quantifiable answers,
leading to a total score that can range from 12 (least
problems) to 60 (most problems). For our study popula-
tion we will use the Dutch version. This version is be-
lieved to have excellent test-retest reliability (ICC = 0.97)
and a very high correlation with the visual analogue
scale score of the hip (r ≥ 0.7) [19]. Changes in the OHS
are also closely related to the patients’ satisfaction with
their surgery [20,21]. Furthermore, it is very sensitive to
change in the first postoperative year [19].
The SF-36 is a generic questionnaire that contains 36
items measuring health on eight different dimensions.
These dimensions cover functional status, wellbeing
and overall evaluation of health. It draws attention to
broader problems of physical functioning than the OHS
[22]. The SF-36 is not very sensitive to individual
changes, but is effective for measuring group changes,
so it becomes a good instrument for scientific research
[23]. Internal-consistency reliability of the Dutch version
meets the 0.70 level (Cronbach’s alpha) recommended
for group comparisons on all scales (range: 0.78 to
0.92). The PF and Bodily Pain (BP) scales even met or
exceeded the 0.90 level recommended for individual
comparisons [24].
Functional measures
All patients will have functional measurements recorded
using the TGUG test, the Five Times Sit-to-Stand test
(5tSTS) and the Six-Minute Walk (6MWT) test. In the
TGUG test, the participant is asked to stand up and
walk 3 m, turn around and walk back to the chair and to
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complete the test expressed in seconds [25]. Yeung et al.
investigated the psychometric properties of the TGUG
test in inpatients on an orthopedic rehabilitation ward
[26]. They found a high ICC (0.80). The standard error
of measurement was 10.2 seconds. Change in TGUG
scores correlated with the changes in pain (r = 0.21;
P <0.01) and function (r = −0.23; P <0.01).
The 5tSTS test is an easily feasible test where the pa-
tient has to stand up and sit back down five times as
quickly as possible is a good predictor of falling. A worse
score (a longer time needed to complete the test) on the
5tSTS implies a greater chance of falling [27]. Further-
more it predicts problems with daily activities [28]. The
test-retest reliability is good to high (ICC 0.64 to .096) in
most populations and settings and validity is scored
good (compared to 1 Repetition Maximum (1RM) leg
press, Pearson correlation coefficient r = 0.68, P <0.05)
[29,30]. The standard error of measurement (6.3% of
mean 5tSTS) and the minimum detectable change
(17.5% of mean 5tSTS) are low [31].
The 6MWT requires a 30 m hallway, but no exercise
equipment or advanced training for technicians. The test
measures the distance a patient can quickly walk on a
flat, hard surface in a time-period of six minutes (the
six-minute walking distance (6MWD)). The test will be
carried out according to the American Thoracic Society
guidelines [32]. This means there will be a standard
instruction and demonstration prior to the test; the re-
searcher is not allowed to walk with the patient. No ver-
bal feedback is given. Every minute the remaining time
is mentioned with a standard phrase of encouragement,
spoken in a neutral tone. The timer is started when the
patient starts walking. The test-retest reliability is excel-
lent (ICC 0.95). The 6MWD is significantly greater for
active than for inactive adults (P <0.0001). It moderately
correlates with chair stands (r = 0.67), standing balance
(r = 0.52), gait speed (r = −0.73) and self-reported phys-
ical functioning (r = 0.55) [33].
Intervention
All patients will get a standard THR (cementless hydroxyapatite-
coated cup and a titanium plasma-sprayed stem (Wright
Medical, Warshaw, USA)) with a ceramic-on-ceramic
(third generation BIOLOX™ delta (Wright Medical,
Warshaw, USA) couple. Preoperative leg length and off-
set are marked to reconstruct the preoperative leg
length and to obtain the optimal offset.
In the AA group, a standard transgluteal approach is
used and the most optimal component position is
achieved. In the PAA group, a muscle sparing technique
is used. This will not compromise the component pos-
ition, but fewer release and detachment of the gluteus
medius is necessary. Both groups will receive usual care(UC) after surgery. This includes standard physiotherapy
care consisting of mobilizing and strengthening tech-
niques. All patients will receive a booklet containing in-
formation about the surgery, weight-bearing capacity
after the surgery and rehabilitation in general.
Follow-up measurements
All measurements will be repeated at four weeks and
three months post-surgery. Six weeks post-surgery pa-
tients will be seen by the orthopedic surgeon for clinical
and radiographic control. These are routine measure-
ments to assess the postoperative course.
Randomization, blinding and treatment allocation
Patients will be allocated to one of two treatment groups
by the surgeon at the preoperative consultation.
Randomization will take place by means of blinded en-
velopes. In total 10 envelopes are provided: five that allo-
cate the patient to the AA group and five that allocate
the patient to the PAA group. This is to ensure that the
same number of patients is randomized in one of the
two treatment groups. Patients receive the same infor-
mation from the surgeon regardless of their group allo-
cation. A blinded researcher will perform baseline and
follow-up measurements. To ensure blinded assessment,
SEMG will be carried out by an independent researcher.
This because blinding is not possible due to different lo-
cations of scar tissue.
Power and sample size calculation
Starting with a pilot study, we will include five people in
each group. On this basis we will do power and sample
size calculations in order to commence with the ran-
domized controlled trial.
Analysis
The primary outcome measure will be the score on the
TGUG. Secondary outcome measures will include
SEMG, strength of quadriceps and gluteus medius, OHS
and SF-36 questionnaire score, score on the 5tSTS, the
Trendelenburg test score and the 6MWT score. Normal-
ity of data will be checked via the Kolmogorov-Smirnov
test. Differences between both treatment groups at base-
line and follow-up measurements will be analyzed using
the chi-square statistical method for categorical vari-
ables. For continuous variables, comparisons between
both groups’ baselines will be made using an independ-
ent samples t-test. Comparisons between both groups at
the follow-up measurements will be made using a two-
factor repeated measures Analysis of Variance (ANOVA)
(group × time). Baseline values will be included as the
first follow-up measurements. Differences between suc-
cessive measurements within a treatment group will be
analyzed using a one-factor repeated measures ANOVA.
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sults of all subjects will be analyzed, regardless of their
treatment adherence (intention-to-treat analysis).
Discussion
The aim of this study is to assess the difference in func-
tional outcome after THR through the PAA, compared
to THR through the AA. The main difference between
these two approaches is their impact on the gluteus
medius. Whereas the AA detaches two thirds of the glu-
teus medius, the PAA only detaches a small part of the
muscle. Since the gluteus medius is one of the most im-
portant muscles for the stability of the hip joint [10-12],
we hypothesize that functional outcome is better or is
achieved faster if THR surgery is performed through the
PAA instead of the AA.
For this study we chose to have multiple outcome
measures (SEMG, strength of gluteus medius and quad-
riceps, the Trendelenburg test score, the 6MWD and
scores on the OHS, SF-36, TGUG and 5tSTS tests) to be
certain we measure all possible effects. According to
Vissers et al. three aspects should measure functional
outcome: self-perceived function, functional tests in a la-
boratory setting and actual daily activity [4]. Both self-
perceived function (measured by the OHS and SF-36
questionnaires) and functional tests (measured by the
6MWT and the TGUG, 5tSTS and tests) are use as out-
come measures in our study. However, we chose not to
assess actual daily activity at this stage. Rasch et al. re-
ported remaining muscle atrophy up to two years after
THR [5]. Therefore, we chose to include muscle strength
measurements (measured by the SEMG, MicroFET and
Trendelenburg tests). If this protocol takes too much ef-
fort for our patients it is possible that we could reduce it
by removing the 6MWT and the Trendelenburg test.
This study has the following limitations. First, complete
blinding cannot be achieved because of the SEMG mea-
surements of the gluteus medius and the difference in
location of scar tissue for both surgical approaches. There-
fore, we chose to have an independent researcher carry
out SEMG measurements and note the results, ensuring
the other measures will be blinded. Second, we will only
evaluate the short-term outcome. Because of the differ-
ence in approach we assume that the intervention group
will already show a great deal of improvement in the
short-term, while the control group will improve less. In
later studies it will be necessary to investigate long-term
success as well.
The following strengths can be mentioned. First, we
conduct a single centre study, ensuring a standardized
approach. Second, we use a wide range of outcome mea-
sures allowing us to achieve a total picture of the re-
habilitation process. This is why patients are asked to
complete both a generic (SF-36) and a disease-specificquestionnaire (OHS). The disease-specific questionnaire
is believed to better measure changes in function. The
generic questionnaire is used to detect changes in
psychosocial terms as well.
Trial status
Statistical analysis. Recruitement began October 2013
and was finished in September 2014.
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